Abstract
Although an annual screening programme for lung cancer has been carried out widely in Japan since 1987, there is insufficient evidence to confirm its efficacy in terms of reducing mortality. In order to evaluate the efficacy of the lung cancer screening which has been widely carried out in Japan since 1987, a case–control study was conducted in Niigata Prefecture, Japan. In the study area, chest X-ray examinations for all participants and sputum cytology for high-risk participants were offered annually. Case subjects, who had died from lung cancer (174), and control subjects matched by sex, year of birth, residence and smoking status (801), who had been alive at the time of diagnosis of the corresponding case, were selected from the National Health Insurance holders. Screening histories of the subjects were compared between cases and matched controls for the identical calendar period before the time of diagnosis of the cases. The odds ratio of death from lung cancer for those screened within 12 months vs those not screened was 0.401 (95% CI: 0.272–0.591) with adjustment by smoking index. Our results suggest that annual lung cancer screening might reduce mortality from lung cancer by approximately 60%. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Clark EA and Anderson TW (1979) Does screening by “pap” smears help prevent cervical cancer?. Lancet 2: 1–4
Cole P and Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263–1272
Cronin KA, Weed DL, Connor RJ and Prorok PC (1998) Case–control studies of cancer screening: theory and practice. J Natl Cancer Inst 90: 498–504
Ebeling K and Nischan P (1987) Screening for lung cancer-results from a case–control study. Int J Cancer 40: 141–144
Ebeling K, Nischan P and Zellmer C (1987) Survival rates of asymptomatic or symptom-detected cases of lung cancer. Arch Geschwulstforsch 57: 61–67
Faivre J, Tazi MA, Mrini TEI, Lejeune C, Benhamiche AM and Dassonville F (1999) Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79: 680–683
Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE and Muhm JR (1986) Lung cancer screening: the Mayo Program. J Occup Med 28: 746–750
Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, Mcguinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK and Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354: 99–105
Hosek RS, Flanders WD and Sasco AJ (1996) Bias in case-control studies of screening effectiveness. Am J Epidemiol 143: 193–201
Kubik A, Parkin DM, Khlat M, Erban J, Polak J and Adamec M (1990) Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 45: 26–33
Melamed MR and Flehinger BJ (1987) Detection of lung cancer: highlights of the Memorial Sloan-Kettering Study in New York City. Schweiz Med Wschr 117: 1457–1463
Sobue T, Suzuki T and Naruke T The Japanese Lung-cancer-Screening Research Group (1992) A case-control study for evaluation lung-cancer screening in Japan. Int J Cancer 50: 230–237
Tockman MS (1986) Survival and mortality from lung cancer in a screened population: the Johns Hopkins study. Chest 89, (Suppl).324–325
Tsukada H, Yokoyama A, Kurita Y and Misawa H (2000) Evaluation of population-based lung cancer screening in Niigata and analysis of interval cases based on comparison lung cancer registry with screening records. J Jpn Respir Soc 38: 501–508, (in Japanese)
UICC (1992) TNM classification of malignant tumours, 4th ed., 2nd revision, pp 77–80, Springer-Verlag: New York
Weiss NS and Lazovich D (1996) Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome. Am J Epidemiol 143: 319–322
Yokoyama A (1999) Evaluation of screening for lung cancer. In:The reports of the tasks evaluating cancer screening in Niigata Prefecture, 85–88, (in Japanese)
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tsukada, H., Kurita, Y., Yokoyama, A. et al. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case–control study. Br J Cancer 85, 1326–1331 (2001). https://doi.org/10.1054/bjoc.2001.2060
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2060
Keywords
This article is cited by
-
Association of employment and company size with lung cancer screening participation among Japanese based on the socioeconomic conditions using the Comprehensive Survey of Living Conditions
International Journal of Clinical Oncology (2020)
-
Lung cancer screening and its efficacy
General Thoracic and Cardiovascular Surgery (2009)
-
Lung cancer screening
Current Oncology Reports (2007)
-
Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy
The Japanese Journal of Thoracic and Cardiovascular Surgery (2005)